The FAERS Public Dashboard and its Value to the Pharmaceutical Industry
Jul 31, 2018 - 00:24:45
Radio and PodcastLive Radio & PodcastsLoading episode
Fetching episode details...
Radio and PodcastLive Radio & PodcastsRadio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & PodcastsFDA medical oncologists discuss the agency’s accelerated approval of rucaparib for treatment of patients with deleterious BRCA mutation-associated advanced ovarian cancer who have been treated with two or more chemothera...
FDA D.I.S.C.O.: Rucaparib in Ovarian Cancer is an episode from FDA Drug Information Updates by ReachMD. FDA medical oncologists discuss the agency’s accelerated approval of rucaparib for treatment of patients with deleterious BRCA mutation-...
This episode belongs to FDA Drug Information Updates.
Use the player on this page to stream the episode online.
Published May 17, 2017, 00:05:00 long, audio available.
Continue listening to more episodes from FDA Drug Information Updates.
Jul 31, 2018 - 00:24:45
May 4, 2018 - 00:02:59
Jan 7, 2018 - 00:08:29
Jan 5, 2018 - 00:02:59
Oct 29, 2017 - 00:09:22
Aug 17, 2017 - 00:05:29
Jul 28, 2017 - 00:06:00
FDA medical oncologists discuss the agency’s accelerated approval of rucaparib for treatment of patients with deleterious BRCA mutation-associated advanced ovarian cancer who have been treated with two or more chemotherapies. Released May 17, 2017
You can listen to FDA D.I.S.C.O.: Rucaparib in Ovarian Cancer online on Radio and Podcast. Open the player on this page to stream the available audio.
FDA D.I.S.C.O.: Rucaparib in Ovarian Cancer is an episode from FDA Drug Information Updates by ReachMD.
This episode is 00:05:00 long.
This episode was published on May 17, 2017.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from FDA Drug Information Updates when more episodes are available from the podcast feed.
You can listen to FDA D.I.S.C.O.: Rucaparib in Ovarian Cancer on this page when the episode audio is available from the podcast feed.
FDA D.I.S.C.O.: Rucaparib in Ovarian Cancer is from FDA Drug Information Updates by ReachMD.
Published May 17, 2017 and 00:05:00 long